MedPlus Health Services intimated a revised board meeting on May 20, 2026, to approve audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
The trading window for designated persons remains closed from April 1, 2026, to May 22, 2026, as per SEBI insider trading regulations.
The audited financial results will be submitted to stock exchanges post-meeting and published on the company website and in newspapers.